These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

760 related items for PubMed ID: 8994249

  • 1. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
    Jauniaux E, Gulbis B, Tunkel S, Ramsay B, Campbell S, Meuris S.
    Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
    [Abstract] [Full Text] [Related]

  • 2. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR, Lopes AM, Benn PA, Lerer T, Steinfeld JD, Ingardia CJ.
    J Matern Fetal Med; 2000 Dec; 9(3):161-4. PubMed ID: 10914623
    [Abstract] [Full Text] [Related]

  • 3. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP, Sikkema-Raddatz B, Beekhuis JR, De Wolf BT, Mantingh A.
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [Abstract] [Full Text] [Related]

  • 4. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V, Chernev T, Vragaleva S, Slŭncheva B, Mikhaĭlova E, Kremenski I, Simeonov E.
    Akush Ginekol (Sofiia); 2002 Sep; 41(6):3-12. PubMed ID: 12577497
    [Abstract] [Full Text] [Related]

  • 5. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A, Wilson RD, SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA GENETICS COMMITTEE.
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [Abstract] [Full Text] [Related]

  • 6. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K.
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [Abstract] [Full Text] [Related]

  • 7. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
    Benn PA, Horne D, Briganti S, Rodis JF, Clive JM.
    Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
    [Abstract] [Full Text] [Related]

  • 8. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
    Zheng MM, Hu YL, Zhang CY, Ru T, Liu QL, Xu BY, Chen QG, Xu ZF, Zhang Y, Zhong XL.
    Chin Med J (Engl); 2010 Mar 05; 123(5):555-8. PubMed ID: 20367980
    [Abstract] [Full Text] [Related]

  • 9. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
    Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M.
    Obstet Gynecol; 1992 Jul 05; 80(1):83-6. PubMed ID: 1603504
    [Abstract] [Full Text] [Related]

  • 10. Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
    Räty R, Anttila L, Virtanen A, Koskinen P, Laitinen P, Mörsky P, Tiitinen A, Martikainen H, Ekblad U.
    Prenat Diagn; 2003 Dec 30; 23(13):1045-8. PubMed ID: 14691989
    [Abstract] [Full Text] [Related]

  • 11. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA.
    Prenat Diagn; 1998 Apr 30; 18(4):319-24. PubMed ID: 9602476
    [Abstract] [Full Text] [Related]

  • 12. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
    Toal M, Chaddha V, Windrim R, Kingdom J.
    J Obstet Gynaecol Can; 2008 Mar 30; 30(3):198-206. PubMed ID: 18364097
    [Abstract] [Full Text] [Related]

  • 13. Maternal serum markers levels in consecutive pregnancies: a possible genetic predisposition to abnormal levels.
    Dar H, Merksamer R, Berdichevsky D, David M.
    Am J Med Genet; 1996 Jan 11; 61(2):154-7. PubMed ID: 8669443
    [Abstract] [Full Text] [Related]

  • 14. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
    Tanaka M, Natori M, Ishimoto H, Gohda N, Kiyokawa K, Yamauchi J, Miyazaki T, Kobayashi T, Nozawa S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov 11; 46(11):1229-33. PubMed ID: 7531210
    [Abstract] [Full Text] [Related]

  • 15. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
    Cusick W, Rodis JF, Vintzileos AM, Albini SM, McMahon M, Campbell WA.
    J Reprod Med; 1996 May 11; 41(5):327-32. PubMed ID: 8725757
    [Abstract] [Full Text] [Related]

  • 16. Adverse outcome of pregnancies with extremely high levels of maternal serum human chorionic gonadotropin.
    Sharony R, Itzhaky D, Amiel A, Hershko A, Grinshpoon Y, Fejgin M.
    Fetal Diagn Ther; 2008 May 11; 23(3):233-6. PubMed ID: 18417984
    [Abstract] [Full Text] [Related]

  • 17. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
    Hershkovitz R, Erez O, Sheiner E, Landau D, Mankuta D, Mazor M.
    Acta Obstet Gynecol Scand; 2003 Jan 11; 82(1):22-7. PubMed ID: 12580835
    [Abstract] [Full Text] [Related]

  • 18. Dependence of maternal serum [AFP]/[hCG] median ratios on age of gestation: comparison of trisomy 21 to euploid pregnancies.
    Marcus-Braun N, Birk O, Manor E, Segal D, Harari G, Toma I, Shalev S, Borochowitz ZU, Yaron Y, Sharony R, Itzhaky D, Shtoyerman R, Appelman Z, Braun G.
    Prenat Diagn; 2009 Dec 11; 29(12):1130-4. PubMed ID: 19777489
    [Abstract] [Full Text] [Related]

  • 19. Lack of association between unexplained elevated maternal serum alpha fetoprotein and/or human chorionic gonadotropin and the occurrence of placental thrombotic lesions.
    Salim R, Okopnik M, Garmi G, Nachum Z, Zafran N, Shalev E.
    Placenta; 2010 Apr 11; 31(4):277-81. PubMed ID: 20132984
    [Abstract] [Full Text] [Related]

  • 20. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
    Hurley TJ, Miller C, O'Brien TJ, Blacklaw M, Quirk JG.
    J Matern Fetal Med; 1996 Apr 11; 5(6):340-4. PubMed ID: 8972411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.